Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02837276 · ClinicalTrials.gov registry record
Intermittent Hypoxemia and Acute Kidney Injury Study (IHAKI Study)
A clinical trial of Acute Kidney Injury and Preterm Infant, sponsored by Elie G. Abu Jawdeh, MD.
- Completed
- Registry status
- 41
- Enrollment target
- 1
- Study location
NCT02837276: Completed study of Acute Kidney Injury and Preterm Infant, sponsored by Elie G. Abu Jawdeh, MD.
NCT02837276 is a study of Acute Kidney Injury and Preterm Infant that has completed, run by Elie G. Abu Jawdeh, MD. The registered enrollment target is 41 participants, below the 2,330-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02837276, a study of Acute Kidney Injury and Preterm Infant, has completed, sponsored by Elie G. Abu Jawdeh, MD.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study aims at investigating the relationship between intermittent hypoxemia (IH) and acute kidney injury (AKI) in preterm infants. AIM 1: Test the hypothesis that intermittent hypoxemia is associated kidney injury in preterm infants, as reflected by a rise in serum creatinine. AIM 2: Test the hypothesis that there is rise in acute kidney injury urinary biomarkers with increased intermittent hypoxemia.
Conditions Studied
Study Locations (1)
Kentucky
- University of Kentucky - Kentucky Children's Hospital - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2016-07 |
| Est. Completion | 2018-01-15 |
What the finished NCT02837276 record still lists
NCT02837276 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 2,330-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Acute Kidney Injury appearing as the primary indexed condition, and to 0 interventions.
NCT02837276 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT02837276 about?
NCT02837276 is a clinical study titled "Intermittent Hypoxemia and Acute Kidney Injury Study (IHAKI Study)". This pilot study aims at investigating the relationship between intermittent hypoxemia (IH) and acute kidney injury (AKI) in preterm infants. AIM 1: Test the hypothesis that intermittent hypoxemia is associated kidney injury in preterm infants, as reflected by a rise in serum creatinine. AIM 2: Te...
What is the current status of trial NCT02837276?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2016-07. Estimated completion is 2018-01-15.
What conditions does trial NCT02837276 study?
This clinical trial studies the following conditions: Acute Kidney Injury, Preterm Infant, Intermittent Hypoxemia.
Who is sponsoring clinical trial NCT02837276?
This trial is sponsored by Elie G. Abu Jawdeh, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02837276 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02837276's enrollment target sits among peer trials
41 60th of 74 higher than 15 of 74 other Acute Kidney Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Kidney Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ultra-Low Contrast Angiography in AKI
RECRUITING · Phase 3
-
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
RECRUITING
-
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
RECRUITING
-
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
RECRUITING · Phase 2
-
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
RECRUITING · Phase 1
-
Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia